191 related articles for article (PubMed ID: 15492239)
1. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.
Fukino K; Shen L; Matsumoto S; Morrison CD; Mutter GL; Eng C
Cancer Res; 2004 Oct; 64(20):7231-6. PubMed ID: 15492239
[TBL] [Abstract][Full Text] [Related]
2. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
Moinfar F; Man YG; Arnould L; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer Res; 2000 May; 60(9):2562-6. PubMed ID: 10811140
[TBL] [Abstract][Full Text] [Related]
3. Breast-cancer stromal cells with TP53 mutations and nodal metastases.
Patocs A; Zhang L; Xu Y; Weber F; Caldes T; Mutter GL; Platzer P; Eng C
N Engl J Med; 2007 Dec; 357(25):2543-51. PubMed ID: 18094375
[TBL] [Abstract][Full Text] [Related]
4. Presence of genetic alterations in microdissected stroma of human colon and breast cancers.
Wernert N; Löcherbach C; Wellmann A; Behrens P; Hügel A
Anticancer Res; 2001; 21(4A):2259-64. PubMed ID: 11724280
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
[TBL] [Abstract][Full Text] [Related]
6. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
[TBL] [Abstract][Full Text] [Related]
8. [Genetic alterations in the fibroblastic stroma of invasive colon and breast carcinomas].
Wernert N; Hügel A; Löcherbach C
Verh Dtsch Ges Pathol; 1998; 82():317-21. PubMed ID: 10095452
[TBL] [Abstract][Full Text] [Related]
9. [Frequent allelic losses in tumor-associated stromal cells and tumor epitelium of prostate cancer].
Kekeeva TV; Popova OP; Shegaĭ PV; Zavalishina LE; Andreeva IuIu; Zaletaev DV; Nemtsova MV
Mol Biol (Mosk); 2008; 42(1):96-101. PubMed ID: 18389625
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
[TBL] [Abstract][Full Text] [Related]
11. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions.
Kurose K; Hoshaw-Woodard S; Adeyinka A; Lemeshow S; Watson PH; Eng C
Hum Mol Genet; 2001 Sep; 10(18):1907-13. PubMed ID: 11555627
[TBL] [Abstract][Full Text] [Related]
12. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.
Weber F; Shen L; Fukino K; Patocs A; Mutter GL; Caldes T; Eng C
Am J Hum Genet; 2006 Jun; 78(6):961-72. PubMed ID: 16685647
[TBL] [Abstract][Full Text] [Related]
13. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
15. Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis.
Yagishita H; Yoshida T; Ishiguro K; Numata Y; Okayasu I
Scand J Gastroenterol; 2008; 43(5):559-66. PubMed ID: 18415748
[TBL] [Abstract][Full Text] [Related]
16. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma.
Fukino K; Shen L; Patocs A; Mutter GL; Eng C
JAMA; 2007 May; 297(19):2103-11. PubMed ID: 17507346
[TBL] [Abstract][Full Text] [Related]
17. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
[TBL] [Abstract][Full Text] [Related]
18. Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy.
Oudin C; Bonnetain F; Boidot R; Végran F; Soubeyrand MS; Arnould L; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2007 May; 30(5):1145-51. PubMed ID: 17390016
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate.
McCarthy RP; Zhang S; Bostwick DG; Qian J; Eble JN; Wang M; Lin H; Cheng L
Am J Pathol; 2004 Oct; 165(4):1395-400. PubMed ID: 15466403
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
